BioStem Appoints Katherine Gorrell as Chief Legal & Compliance Officer

BioStem Technologies (OTC: BSEM), a leading regenerative medicine company specializing in perinatal tissue allograft products, has announced the appointment of Katherine Gorrell as Chief Legal & Compliance Officer, effective April 27, 2026. Gorrell brings over two decades of experience advising healthcare organizations through complex regulatory, governance, and growth initiatives. In her new role, she will oversee BioStem's legal and compliance functions and play a central role in enterprise governance, including the integration and oversight of Medical Affairs through the company's compliance framework. This move comes as BioStem prepares for a Nasdaq uplisting, signaling a strategic focus on strengthening its leadership team to support scaling and operational excellence. Jason Matuszewski, Chairman and CEO, emphasized Gorrell's ability to partner with boards and executive teams, reinforcing BioStem's foundation of integrity and compliance.

Most recently, Gorrell served as Vice President and General Counsel at Holy Cross Health in Fort Lauderdale, FL, where she led legal strategy across a complex healthcare enterprise. She previously held roles as General Counsel and Compliance Officer for AdvancedMD, a national healthcare IT company, and in-house positions at Intermountain Healthcare and Providence Health & Services/Swedish Health Services. Gorrell holds a JD with Honors, with a concentration in Health Law, from the University of Washington School of Law. Her appointment is expected to support BioStem's growth and evolution, as she expressed enthusiasm for working with the leadership team and board to strengthen governance and ensure legal, compliance, and medical affairs functions evolve with the business.

BioStem Technologies is a publicly traded biomedical innovator focused on developing, manufacturing, and commercializing advanced allograft solutions derived from perinatal tissue. The company leverages proprietary processing technologies such as BioRetain®, CryoTek®, and SteriTek® to preserve the natural properties of tissues. Its portfolio includes brands like Neox®, Clarix®, VENDAJE®, and American Amnion™. For more information, follow BioStem on X and LinkedIn. The company's newsroom can be accessed at https://tinyurl.com/bsemnewsroom for the latest updates on $BSEM.